UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nonlinearities of an Aircraft Piccolo Tube: Identification and Modeling

Model Validation and Uncertainty Quantification, Volume 3, 2018, p.57-59

2018

Volltextzugriff (PDF)

Multicenter Phase II Trial of Neoadjuvant Therapy With Trastuzumab, Docetaxel, and Carboplatin for Human Epidermal Growth Factor Receptor-2–Overexpressing Stage II or III Breast Cancer: Results of the GETN(A)-1 Trial

Journal of clinical oncology, 2007-07, Vol.25 (19), p.2678-2684

2007

Volltextzugriff (PDF)

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

The Lancet (British edition), 2019-06, Vol.393 (10191), p.2591-2598

2019

Volltextzugriff (PDF)

Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy

Journal of clinical oncology, 1999-05, Vol.17 (5), p.1413-1424

1999

Volltextzugriff (PDF)

Phase II Study of Oral Vinorelbine in First-Line Advanced Breast Cancer Chemotherapy

Journal of clinical oncology, 2003-01, Vol.21 (1), p.35

2003

Volltextzugriff (PDF)

EPICC study: evaluation of pharmaceutical intervention in cancer care

Journal of clinical pharmacy and therapeutics, 2015-04, Vol.40 (2), p.196-203

2015

Volltextzugriff (PDF)

Addition of Oxaliplatin to Continuous Fluorouracil, l-Folinic Acid, and Concomitant Radiotherapy in Rectal Cancer: The Lyon R 97-03 Phase I Trial

Journal of clinical oncology, 2001-05, Vol.19 (9), p.2433-2438

2001

Volltextzugriff (PDF)

Cancer-associated thrombosis in patients with implanted ports: a prospective multicenter French cohort study (ONCOCIP)

Blood, 2018-08, Vol.132 (7), p.707-716

2018

Volltextzugriff (PDF)

SIMMEON-Prep study: SIMulation of Medication Errors in ONcology: prevention of antineoplastic preparation errors

Journal of clinical pharmacy and therapeutics, 2015-02, Vol.40 (1), p.55-62

2015

Volltextzugriff (PDF)

Actionable molecular alterations in advanced gynecologic malignancies: updated results from the ProfiLER program in France

Annals of oncology, 2017-10, Vol.28, p.vii14-vii14

2017

Volltextzugriff (PDF)

IL-15Rα membrane anchorage in either cis or trans is required for stabilization of IL-15 and optimal signaling

Journal of cell science, 2020-03, Vol.133 (5)

2020

Volltextzugriff (PDF)

Phase I dose-escalation study of aflibercept in combination with docetaxel and cisplatin in patients with advanced solid tumours

British journal of cancer, 2012-08, Vol.107 (4), p.598-603

2012

Volltextzugriff (PDF)

646: Predicting colon cancer occurrence from transcriptomic, splicing and genomic data in colon adenomas

European journal of cancer (1990), 2014-07, Vol.50, p.S154-S154

2014

Volltextzugriff (PDF)

Actionable molecular alterations in advanced gynecologic malignancies: First results from the ProfiLER program (NCT01774409) in France

Annals of oncology, 2017-09, Vol.28, p.v333-v333

2017

Volltextzugriff (PDF)

Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy

European journal of cancer (1990), 1993, Vol.29 (3), p.319-324

1993

Volltextzugriff (PDF)

Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes

Annals of oncology, 2016-10, Vol.27, p.vi53-vi53

2016

Volltextzugriff (PDF)

Effects of HER2 immuno-histochemistry expression levels on survival in patients treated by trastuzumab at the adjuvant setting in the SIGNAL/PHARE prospective cohort

Annals of oncology, 2016-10, Vol.27, p.vi55-vi55

2016

Volltextzugriff (PDF)

Assessment of tumour response to chemotherapy for metastatic colorectal cancer: accuracy of the RECIST criteria

British journal of radiology, 2002-11, Vol.75 (899), p.903-908

2002

Volltextzugriff (PDF)

Oral vinorelbine: Feasibility and safety profile

Annals of oncology, 2001-12, Vol.12 (12), p.1677-1681

2001

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy

Targeted oncology, 2015-12, Vol.10 (4), p.583-596

2015

Volltextzugriff (PDF)

Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure

British journal of cancer, 2000-08, Vol.83 (4), p.431-437

2000

Volltextzugriff (PDF)

Population pharmacokinetics of doxorubicin, etoposide and ifosfamide in small cell lung cancer patients: results of a multicentre study

British journal of clinical pharmacology, 2000-10, Vol.50 (4), p.315-324

2000

Volltextzugriff (PDF)

Any Clinical Benefit From the Use of Oncofoetal Markers in the Management of Chemotherapy for Patients with Metastatic Colorectal Carcinomas?

Clinical oncology (Royal College of Radiologists (Great Britain)), 2004-05, Vol.16 (3), p.196-203

2004

Volltextzugriff (PDF)

Chemotherapy may be delivered based on an integrated view of tumour dynamics

IET systems biology, 2009-05, Vol.3 (3), p.180-190

2009

Volltextzugriff (PDF)

1 – 25 von 181

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(149)
Mit Volltextzugriff
(84)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(118)
Female
(70)
Middle Aged
(66)
Science & Technology
(63)
Life Sciences & Biomedicine
(62)
Male
(61)
Adult
(54)
Oncology
(38)
Aged
(36)
Biological And Medical Sciences
(30)
Medical Sciences
(30)
Sciences Biologiques Et Medicales
(26)
Sciences Medicales
(26)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(23)
Chemotherapy
(20)
Pharmacology. Drug Treatments
(17)
Antineoplastic Agents
(16)
Combined Modality Therapy
(13)
Lung Neoplasms - Drug Therapy
(13)
Treatment Outcome
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nonlinearities of an Aircraft Piccolo Tube: Identification and Modeling

Multicenter Phase II Trial of Neoadjuvant Therapy With Trastuzumab, Docetaxel, and Carboplatin for Human Epidermal Growth Factor Receptor-2–Overexpressing Stage II or III Breast Cancer: Results of the GETN(A)-1 Trial

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial

Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy

Phase II Study of Oral Vinorelbine in First-Line Advanced Breast Cancer Chemotherapy

EPICC study: evaluation of pharmaceutical intervention in cancer care

Addition of Oxaliplatin to Continuous Fluorouracil, l-Folinic Acid, and Concomitant Radiotherapy in Rectal Cancer: The Lyon R 97-03 Phase I Trial

Cancer-associated thrombosis in patients with implanted ports: a prospective multicenter French cohort study (ONCOCIP)

SIMMEON-Prep study: SIMulation of Medication Errors in ONcology: prevention of antineoplastic preparation errors

Actionable molecular alterations in advanced gynecologic malignancies: updated results from the ProfiLER program in France

IL-15Rα membrane anchorage in either cis or trans is required for stabilization of IL-15 and optimal signaling

Phase I dose-escalation study of aflibercept in combination with docetaxel and cisplatin in patients with advanced solid tumours

646: Predicting colon cancer occurrence from transcriptomic, splicing and genomic data in colon adenomas

Actionable molecular alterations in advanced gynecologic malignancies: First results from the ProfiLER program (NCT01774409) in France

Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy

Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes

Effects of HER2 immuno-histochemistry expression levels on survival in patients treated by trastuzumab at the adjuvant setting in the SIGNAL/PHARE prospective cohort

Assessment of tumour response to chemotherapy for metastatic colorectal cancer: accuracy of the RECIST criteria

Oral vinorelbine: Feasibility and safety profile

Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy

Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure

Population pharmacokinetics of doxorubicin, etoposide and ifosfamide in small cell lung cancer patients: results of a multicentre study

Any Clinical Benefit From the Use of Oncofoetal Markers in the Management of Chemotherapy for Patients with Metastatic Colorectal Carcinomas?

Chemotherapy may be delivered based on an integrated view of tumour dynamics

Suchergebnisse filtern